Cargando…

Reliability and Validity of the HIV Disability Questionnaire (HDQ) with Adults Living with HIV in the United States

OBJECTIVES: To assess measurement properties of the HIV Disability Questionnaire (HDQ) among adults with HIV in the United States. METHODS: We administered the HDQ, World Health Organization Disability Assessment Schedule II (WHODAS 2.0), and a demographic questionnaire. For internal consistency rel...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Brien, Kelly Kathleen, Kietrys, David, Galantino, Mary Lou, Parrott, James Scott, Davis, Tracy, Tran, Quang, Aubry, Rachel, Solomon, Patricia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6880031/
https://www.ncbi.nlm.nih.gov/pubmed/31769326
http://dx.doi.org/10.1177/2325958219888461
Descripción
Sumario:OBJECTIVES: To assess measurement properties of the HIV Disability Questionnaire (HDQ) among adults with HIV in the United States. METHODS: We administered the HDQ, World Health Organization Disability Assessment Schedule II (WHODAS 2.0), and a demographic questionnaire. For internal consistency reliability, we calculated Cronbach α and Kuder-Richardson-20 (KR-20) statistics for disability and episodic scores, respectively (≥0.80 acceptable). For test–retest reliability, we calculated intraclass correlation coefficients (>0.8 acceptable). For construct validity, we tested 15 a priori hypotheses assessing correlations between HDQ and WHODAS 2.0 scores. RESULTS: Of the 128 participants, the majority were males (68%), median age 51 years, taking antiretroviral therapy (96%). Cronbach α ranged from 0.88 (social inclusion) to 0.93 (uncertainty). The KR-20 ranged from 0.86 (cognitive) to 0.96 (uncertainty). Intraclass correlation coefficients ranged from 0.88 (physical, cognitive, social inclusion) to 0.92 (mental–emotional). Of the 15 hypotheses, 13 (87%) were confirmed. CONCLUSIONS: The HDQ demonstrates internal consistency reliability, test–retest reliability, and construct validity when administered to a sample of adults with HIV in the United States.